3-hydroxy Phenazepam
(Synonyms: 3-羟基芬纳西泮,3-hydroxy Fenazepam) 目录号 : GC42284An Analytical Reference Material
Cas No.:70030-11-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Phenazepam is an anxiolytic and hypnotic sedative.[1] 3-hydroxy Phenazepam is a major metabolite of phenazepam. [2] [3] There are significant differences in the rate of phenazepam metabolism in different species, so that 3-hydroxy phenazepam can be detected shortly after oral administration of the parent compound in cats, rats, and dogs but not in humans.[3] The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.
Reference:
[1]. Molodavkin, G.M., Voronina, T.A., Chernyavskaya, L.I., et al. Pharmacological activity of phenazepam and flunitrazepam in ultralow doses. Bulletin of Experimental Biology and Medicine 135, 39-41 (2003).
[2]. Maskell, P.D., De Paoli, G., Seetohul, L.N., et al. Phenazepam: The drug that came in from the cold. J.Forensic Leg.Med. 19(3), 122-125 (2012).
[3]. Zherdev, V.P., Caccia, S., Garatini, S., et al. Species differences in phenazepam kinetics and metabolism. European Journal of Drug Metabolism and Pharmacokinetics 7(3), 191-196 (1982).
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.7352 mL | 13.6761 mL | 27.3523 mL |
| 5 mM | 0.547 mL | 2.7352 mL | 5.4705 mL |
| 10 mM | 0.2735 mL | 1.3676 mL | 2.7352 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。